Why is the market design for innovative pharmaceuticals not well understood?
Autor: | Olivença F; Lane Clark & Peacock LLP, London, W1U 1DQ, UK., Diaz J; Global Health Economics & Outcomes Research, Bristol Myers Squibb, Uxbridge, UB8 1DH, UK., Ramagopalan SV; Lane Clark & Peacock LLP, London, W1U 1DQ, UK.; Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK., Garrison LP Jr; The Comparative Health Outcomes, Policy, & Economics (CHOICE) Institute, University of Washington, Seattle, WA 98195-7630, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of comparative effectiveness research [J Comp Eff Res] 2024 Oct; Vol. 13 (10), pp. e240105. Date of Electronic Publication: 2024 Sep 10. |
DOI: | 10.57264/cer-2024-0105 |
Databáze: | MEDLINE |
Externí odkaz: |